Why the study?
Does routine invasive treatment reduce the risk of a composite of all-cause mortality and MI within 1 year in older patients with NSTEACS compared with conservative management?
Does routine invasive treatment reduce the risk of a composite of all-cause mortality and MI within 1 year in older patients with NSTEACS compared with conservative management?
In older patients with NSTEACS, routine invasive management does not reduce 1-year mortality or MI compared to conservative management, but it does reduce the risk of repeat MI and urgent revascularization.
Answers are grounded in this paper and cite their sources.
Supports conservative over routine invasive management in older NSTEACS for mortality/MI prevention; extends evidence of benefit limited to repeat events.
No evidence was found that routine invasive treatment for NSTEACS in older patients reduces the risk of a composite of all-cause mortality and MI within 1 year compared with conservative management. However, there is convincing evidence that invasive treatment significantly lowers the risk of repeat MI or urgent revascularisation. Further evidence is needed from ongoing larger clinical trials.
No takes yet. Share an insight, caveat, or question.
Kotanidis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: